Aspira Women's Health Inc.
AWHL
$0.41
$0.013.41%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.15% | 2.13% | -0.78% | 5.85% | 10.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.15% | 2.13% | -0.78% | 5.85% | 10.28% |
| Cost of Revenue | -8.14% | 2.22% | -13.17% | -23.43% | -5.60% |
| Gross Profit | -3.43% | 2.07% | 7.95% | 28.50% | 22.15% |
| SG&A Expenses | -47.76% | -46.36% | -45.26% | -23.83% | 2.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.24% | -35.28% | -38.17% | -19.58% | -7.74% |
| Operating Income | 62.58% | 57.83% | 58.80% | 31.21% | 17.03% |
| Income Before Tax | -142.72% | -37.92% | 24.48% | 59.97% | 55.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -142.72% | -37.92% | 24.48% | 59.97% | 55.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -142.72% | -37.92% | 24.48% | 59.97% | 55.07% |
| EBIT | 62.58% | 57.83% | 58.80% | 31.21% | 17.03% |
| EBITDA | 62.69% | 58.91% | 58.80% | 31.06% | 16.62% |
| EPS Basic | 5.18% | 41.62% | 73.40% | 78.05% | 72.04% |
| Normalized Basic EPS | -22.93% | 41.63% | 73.38% | 78.05% | 76.55% |
| EPS Diluted | 5.18% | 41.62% | 73.40% | 78.05% | 72.04% |
| Normalized Diluted EPS | -22.93% | 41.63% | 73.38% | 78.05% | 76.55% |
| Average Basic Shares Outstanding | 156.05% | 136.20% | 184.09% | 82.26% | 60.60% |
| Average Diluted Shares Outstanding | 156.05% | 136.20% | 184.09% | 82.26% | 60.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |